BAX Stock: Baxter International Inc. Stock Price, Analysis & Insights
Get live bax stock price $18.25, comprehensive Baxter International Inc. stock analysis, charts, news, and expert forecast. Real-time bax stock data and investment insights.
Loading chart...
Company Overview
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Company Information
- CEO
- David Brent Shafer
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 38000
Contact Information
- Website
- https://www.baxter.com
- Address
- One Baxter Parkway
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.61) may provide portfolio stability
Business Model & Strategy
Baxter International Inc. operates in the Medical - Instruments & Supplies industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO David Brent Shafer, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Instruments & Supplies model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Baxter International Inc. competes in the Medical - Instruments & Supplies within the broader Healthcare. With 9.4 billion in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, Baxter International Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Baxter International Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Baxter International Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Baxter International Inc.
- ⚠Investors should consider how Baxter International Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
9.38B
P/E Ratio
-26.07
Beta
0.61
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 9.38B market capitalization
- Trading Volume: 10.89M shares traded today
- Price Range: 52-week range of $17.47 - $37.74
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Baxter International Inc.
Baxter International Inc. (BAX) operates in the Medical - Instruments & Supplies industry within the Healthcare sector. With a current market capitalization of 9.38B, the company represents a significant player in its market. The stock is currently trading at $18.25 with a positivedaily change of 2.82%.
The company's 38000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -26.07, beta of 0.61, and 52-week price range from $17.47 to $37.74when evaluating investment opportunities.
Why Invest in Baxter International Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under David Brent Shafer
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.